Clinical Trial Update: Safety, Tolerability and Protective Efficacy of PfSPZ Vaccine in Gabonese Children [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing safety, tolerability, and protective efficacy of the PfSPZ Vaccine in Gabonese children for malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• PfSPZ Vaccine (Plasmodium falciparum sporozoite vaccine)

Snippet

Sponsor: Sanaria Inc. | Conditions: Malaria | Phase 2 | Status: COMPLETED